Zefia Welle

PHD Doctor of Philosophy,  Toronto General - University Health Network 

Location: India

Consulting Services

Sales and Marketing Research Consulting Career Advice and Mentoring Biostatistics Pharma-CRO-Device

Areas Of Interest

Disulfide Interchange Enzyme Diaphragmatic Myocardial Infarctions Saccadic Eye Movement Protozoal Meningoencephalitis Injuries, ACL cis Resveratrol Cyclic Depsipeptides Aldolase, Threonine Fusion Proteins, gag-jun Myopathy, Rod Body Cyclin Dependent Kinase Inhibitor 1A Protein Alzheimer Diseases, Familial (FAD) Virus, MERS Agents, Minor Tranquilizing NKR P1 Receptors zeta Globin Disease, Hers Health Complaint, Subjective Reductase, Hydrogensulfite Codon, Termination, Premature Schistosomiasis, Urogenital

Professional Narrative

Dr. Zefia Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2017
Executive Director, Amgen 1993

Education

Director Medicine, Perelman School of Medicine 2018
Director Medicine, Weill Medical College 2004

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :